Company Filing History:
1 out of 580 
1 out of 3,539 
1 out of 3 Years Active: 2020
Title: Zoltan Papp: Innovator in Biomarker Testing for Preeclampsia
Introduction
Zoltan Papp is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of medical diagnostics, particularly in the early detection of preeclampsia and HELLP syndrome. His innovative work has the potential to improve outcomes for pregnant women and their babies.
Latest Patents
Zoltan Papp holds a patent for a biomarker test designed for the prediction or early detection of preeclampsia and/or HELLP syndrome. This patent discloses specific biomarkers that enable early testing for these conditions. The method provided predicts preeclampsia in pregnant women, and it includes a kit that comprises means for assaying a sample from a pregnant woman for the concentrations of the specific biomarkers.
Career Highlights
Throughout his career, Zoltan Papp has worked with esteemed institutions such as Wayne State University and the National Institutes of Health, a component of the US Department of Health & Human Services. His experience in these organizations has contributed to his expertise in medical research and innovation.
Collaborations
Zoltan has collaborated with notable colleagues, including Adi L Tarca and Nandor Than. Their joint efforts have further advanced the research in biomarker testing and its applications in prenatal care.
Conclusion
Zoltan Papp's contributions to the field of biomarker testing represent a significant advancement in the early detection of preeclampsia and HELLP syndrome. His innovative approach has the potential to save lives and improve maternal health outcomes.